Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research (Q26799223)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 2015)

Language	Label	Description	Also known as
English	Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research	scientific article (publication date: 2015)

Statements

scholarly article

0 references

1 reference

30 July 2022

Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research (English)

0 references

systemic lupus erythematosus

1 reference

29 October 2020

medical research

1 reference

8 September 2020

disease progression

1 reference

29 October 2020

author name string

Jamal Mikdashi

1

0 references

Ola Nived

2

0 references

language of work or name

0 references

publication date

20 July 2015

9 references

12 March 2019

13 March 2019

20 June 2019

17 June 2019

22 June 2019

30 June 2019

8 September 2020

29 October 2020

30 July 2022

Arthritis Research and Therapy

9 references

12 March 2019

13 March 2019

20 June 2019

17 June 2019

22 June 2019

30 June 2019

8 September 2020

29 October 2020

30 July 2022

17

0 references

1

0 references

183

0 references

copyright license

Creative Commons Attribution

9 references

12 March 2019

13 March 2019

20 June 2019

17 June 2019

22 June 2019

30 June 2019

8 September 2020

29 October 2020

30 July 2022

copyright status

0 references

on focus list of Wikimedia project

0 references

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

7 April 2017

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

7 April 2017

Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

The BILAG-2004 systems tally--a novel way of representing the BILAG-2004 index scores longitudinally

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

Abatacept for lupus nephritis: alternative definitions of complete response support conflicting conclusions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

International consensus for a definition of disease flare in lupus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

Numerical scoring for the BILAG-2004 index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

Novel evidence-based systemic lupus erythematosus responder index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

The BILAG-2004 index is sensitive to change for assessment of SLE disease activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

From BILAG to BLIPS--disease activity assessment in lupus past, present and future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

Measurement of systemic lupus erythematosus activity in clinical research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 September 2017

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

31 May 2018

The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

Combined oral contraceptives in women with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

SLEDAI-2K for a 30-day window

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

Generic versus disease-specific measures of health-related quality of life in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

Development and Initial Validation of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50: A Reliable Index for Measuring Improvement in Disease Activity

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 years

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures.

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0702-6

21 January 2018

Flares in lupus: Outcome Assessment Trial (FLOAT), a comparison between oral methylprednisolone and intramuscular triamcinolone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 November 2018

The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 November 2018

Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507322

28 November 2018

Systemic lupus erythematosus disease activity index 2000

1 reference

https://pubmed.ncbi.nlm.nih.gov/26189728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/26189728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revised British Isles Lupus Assessment Group 2004 index: A reliable tool for assessment of systemic lupus erythematosus activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/26189728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA

1 reference

https://pubmed.ncbi.nlm.nih.gov/26189728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/26189728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/26189728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S13075-015-0702-6

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

release_bjini2qmljgrvccp2ckmho74hu

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26799223&oldid=2226635747"